158 related articles for article (PubMed ID: 7735826)
1. Antisense strategies for the control of aberrant gene expression.
Sczakiel G
J Hematother; 1994; 3(4):305-13. PubMed ID: 7735826
[TBL] [Abstract][Full Text] [Related]
2. [The application of antisense technology in ophthalmology].
Guo Y; Ge J
Yan Ke Xue Bao; 1998 Jun; 14(2):108-15. PubMed ID: 12580046
[TBL] [Abstract][Full Text] [Related]
3. [Control of gene expression by antisense nucleic acids].
Lebleu B; Clarenc JP; Degols G; Leonetti JP; Milhaud P
C R Seances Soc Biol Fil; 1992; 186(5):560-6. PubMed ID: 1305901
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
5. Antisense-mediated redirection of mRNA splicing.
Vacek M; Sazani P; Kole R
Cell Mol Life Sci; 2003 May; 60(5):825-33. PubMed ID: 12827272
[TBL] [Abstract][Full Text] [Related]
6. Antisense nucleic acids targeted to the thymidylate synthase (TS) mRNA translation start site stimulate TS gene transcription.
DeMoor JM; Vincent MD; Collins OM; Koropatnick J
Exp Cell Res; 1998 Aug; 243(1):11-21. PubMed ID: 9716444
[TBL] [Abstract][Full Text] [Related]
7. Antisense inhibition of oncogene expression.
Neckers L; Whitesell L; Rosolen A; Geselowitz DA
Crit Rev Oncog; 1992; 3(1-2):175-231. PubMed ID: 1312868
[TBL] [Abstract][Full Text] [Related]
8. Short-term and long-term modulation of gene expression by antisense therapeutics.
Sazani P; Vacek MM; Kole R
Curr Opin Biotechnol; 2002 Oct; 13(5):468-72. PubMed ID: 12459339
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications.
Calabretta B
Cancer Res; 1991 Sep; 51(17):4505-10. PubMed ID: 1873794
[No Abstract] [Full Text] [Related]
10. Antisense strategies: functions and applications in immunology.
Varga LV; Tóth S; Novák I; Falus A
Immunol Lett; 1999 Aug; 69(2):217-24. PubMed ID: 10482355
[TBL] [Abstract][Full Text] [Related]
11. The design of antisense RNA.
Sczakiel G
Antisense Nucleic Acid Drug Dev; 1997 Aug; 7(4):439-44. PubMed ID: 9303196
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of oncogene expression in vitro and in vivo by antisense oligonucleotides.
Neckers L; Rosolen A; Fahmy B; Whitesell L
Ann N Y Acad Sci; 1992 Oct; 660():37-44. PubMed ID: 1340154
[No Abstract] [Full Text] [Related]
13. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
14. Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.
Toulmé JJ; Bourget C; Compagno D; Yurchenko L
Parasitology; 1997; 114 Suppl():S45-59. PubMed ID: 9309768
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo pharmacologic activities of antisense oligonucleotides.
Mirabelli CK; Bennett CF; Anderson K; Crooke ST
Anticancer Drug Des; 1991 Dec; 6(6):647-61. PubMed ID: 1663361
[TBL] [Abstract][Full Text] [Related]
16. Influence of capping and polyadenylation on mRNA expression and on antisense RNA mediated inhibition of gene expression.
Bechler K
Biochem Biophys Res Commun; 1997 Dec; 241(1):193-9. PubMed ID: 9405256
[TBL] [Abstract][Full Text] [Related]
17. The role of target accessibility for antisense inhibition.
Sczakiel G; Far RK
Curr Opin Mol Ther; 2002 Apr; 4(2):149-53. PubMed ID: 12044036
[TBL] [Abstract][Full Text] [Related]
18. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
Nesterova M; Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
[TBL] [Abstract][Full Text] [Related]
19. Applications of antisense oligonucleotides in oncology.
Pierga JY; Magdelenat H
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):237-61. PubMed ID: 7920172
[TBL] [Abstract][Full Text] [Related]
20. Oligonucleotides as modulators of cancer gene expression.
Curcio LD; Bouffard DY; Scanlon KJ
Pharmacol Ther; 1997; 74(3):317-32. PubMed ID: 9352587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
